As UK Patent Office Upholds Enigma's PCR Patents, Biogene Exec Says Dispute 'Far from Closed'

Enigma said that the patents in question are no longer open to challenge by any entity. However, an official at Biogene who initiated the patent challenge said that the UK IPO's ruling was against him personally and doesn't preclude other entities such as Biogene from re-challenging the patents in question.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.